Iris Acquisition Holdings LLC 13D and 13G filings for Liminatus Pharma, Inc. Class A Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-08 4:21 pm Purchase | 2025-04-30 | 13D | Liminatus Pharma, Inc. Class A Common Stock LIMN | Iris Acquisition Holdings LLC | 6,900,000 26.500% | 6,900,000 (New Position) | Filing |